Global Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country

The mortality rates for trachea, bronchus, or lung malignant neoplasms among women vary significantly by country. In 2024, Hungary, Iceland, and Denmark show the highest mortality rates. The United States, Mexico, and Costa Rica have experienced notable decreases over recent years. In contrast, Portugal and Spain saw significant increases in 2023, while countries like Lithuania remained stable. Averaged over the last five years, countries with decreasing mortality trends include the US and Australia, indicating effective health measures. Conversely, Greece and Israel saw increases, suggesting potential areas for healthcare intervention.

Future trends to watch involve advancements in healthcare technology and policy changes impacting smoking rates and air quality. These factors may further influence mortality rates globally, especially in countries currently experiencing high rates like Hungary and Iceland. The focus should also be on understanding cultural and environmental influences contributing to these variations.

Top countries in Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country

# 10 Countries Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates Last Year YoY 5-years CAGR
1 1 Hungary 54.1 2023 +0.74% +0.99% View data
2 2 Iceland 44.5 2023 +2.77% +1.16% View data
3 3 Denmark 42.8 2023 -2.95% -1.9% View data
4 4 Canada 41.4 2023 -1.19% -1.52% View data
5 5 Netherlands 37.5 2023 -2.09% -2.05% View data
6 6 United Kingdom 35.9 2023 -2.71% -2.76% View data
7 7 Slovenia 34.5 2023 +2.07% +0.53% View data
8 8 Poland 34.2 2023 +1.18% +0.35% View data
9 9 Croatia 32.1 2023 +1.58% +1.03% View data
10 10 United States 29.9 2023 -5.08% -4.68% View data

Top Countries about Lung Cancer